We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Biofrontera

News List

Biofrontera, Inc., USA, acquires Cutanea Life Sciences, Inc., USA firstwordpharma
March 26, 2019
Biofrontera Inc., USA ("Biofrontera"), a wholly owned subsidiary of Biofrontera AG (NASDAQ ticker symbol: BFRA, ISIN: DE0006046113)……
Biofrontera Receives FDA approval for Upscaling of Batch Size for Ameluz Production americanpharmaceuticalreview
January 09, 2019
Biofrontera announced the U.S. Food and Drug Administration (FDA), and earlier the European Medicines Agency (EMA), have approved the upscaling of the batch size for the production of Ameluz to 35 kg from previously 7 kg....
Sun Pharma Subsidiary Awarded Preliminary Injunctive Relief from Biofrontera americanpharmaceuticalreview
December 27, 2018
DUSA Pharmaceuticals, a wholly owned subsidiary of Sun Pharmaceutical announced that DUSA has been granted preliminary injunctive relief by.....
Biofrontera cleared of wrongdoing in Nasdaq IPO fiercebiotech
December 26, 2018
An independent review has cleared Biofrontera of wrongdoing related to its U.S. IPO. Shareholders had accused Biofrontera of acting contrary to its duties when it priced and sold stock in the U.S.....